全文获取类型
收费全文 | 195297篇 |
免费 | 11225篇 |
国内免费 | 486篇 |
专业分类
耳鼻咽喉 | 2673篇 |
儿科学 | 6198篇 |
妇产科学 | 4004篇 |
基础医学 | 26607篇 |
口腔科学 | 8480篇 |
临床医学 | 14702篇 |
内科学 | 42940篇 |
皮肤病学 | 4835篇 |
神经病学 | 16608篇 |
特种医学 | 6444篇 |
外国民族医学 | 39篇 |
外科学 | 24354篇 |
综合类 | 1628篇 |
现状与发展 | 1篇 |
一般理论 | 70篇 |
预防医学 | 19638篇 |
眼科学 | 3944篇 |
药学 | 12105篇 |
中国医学 | 768篇 |
肿瘤学 | 10970篇 |
出版年
2023年 | 965篇 |
2022年 | 2153篇 |
2021年 | 4047篇 |
2020年 | 2675篇 |
2019年 | 3815篇 |
2018年 | 5282篇 |
2017年 | 3945篇 |
2016年 | 3740篇 |
2015年 | 4400篇 |
2014年 | 5988篇 |
2013年 | 7672篇 |
2012年 | 11767篇 |
2011年 | 12267篇 |
2010年 | 6375篇 |
2009年 | 5719篇 |
2008年 | 9617篇 |
2007年 | 10286篇 |
2006年 | 9551篇 |
2005年 | 9803篇 |
2004年 | 9237篇 |
2003年 | 8398篇 |
2002年 | 6504篇 |
2001年 | 5762篇 |
2000年 | 5757篇 |
1999年 | 5061篇 |
1998年 | 1838篇 |
1997年 | 1549篇 |
1996年 | 1514篇 |
1995年 | 1281篇 |
1994年 | 1254篇 |
1993年 | 1143篇 |
1992年 | 3093篇 |
1991年 | 3049篇 |
1990年 | 2792篇 |
1989年 | 2762篇 |
1988年 | 2542篇 |
1987年 | 2326篇 |
1986年 | 2187篇 |
1985年 | 2090篇 |
1984年 | 1514篇 |
1983年 | 1199篇 |
1982年 | 720篇 |
1981年 | 652篇 |
1980年 | 646篇 |
1979年 | 1154篇 |
1978年 | 780篇 |
1977年 | 653篇 |
1975年 | 708篇 |
1974年 | 735篇 |
1973年 | 694篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
J J de Souza T Perlmann A A Herman O J Ransome R W Kantor 《Suid-Afrikaanse tydskrif vir geneeskunde》1987,71(11):690-692
The value of maternal C-reactive protein (CRP) levels as predictors of fetal and maternal infective morbidity and fetal mortality was assessed prospectively over a 6-month period in all cases of premature rupture of the fetal membranes or suspected premature labour. Statistical analysis of results showed that CRP at a level of 1.32 mg/dl is a sensitive marker of infective morbidity in mother and neonate. Furthermore, there was a significant association between raised CRP levels and low-birth-weight babies, suggesting that intra-uterine infection is a major cause of prematurity in the study population. 相似文献
82.
83.
84.
85.
Alcides José Branco Filho William Kondo Luis Sérgio Nassif Mariana Jorge Garcia Rafael de Almeida Tirapelle Carlos Marcelo Dotti 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2006,10(3):326-331
BACKGROUND: Gastrogastric fistula is a communication between the proximal gastric pouch and the distal gastric remnant, rarely described in the realm of bariatric procedures. The aim of this study was to review the existing literature about this topic and to demonstrate its laparoscopic treatment. METHODS: An extensive literature review found several articles reporting this complication. However, no citation was found describing the steps of the laparoscopic management of this situation. RESULTS: Gastrogastric fistula occurs in up to 6% of Roux-en-Y gastric bypasses. Two theories exist for fistula formation: (1) it is a technical complication derived from the incomplete division of the stomach during the creation of the pouch, and (2) it occurs after a staple-line failure, developing a leak with an abscess, which then drains into the distal stomach forming the fistula. Early symptoms include fever, tachycardia, and abdominal pain. Failure in weight loss is a late clinical sign observed in these patients. Diagnosis is based on radiologic study, upper endoscopy and computed tomography. When identified in the acute postoperative course, laparoscopic treatment is easy. Chronic fistulas are difficult to manage, and the laparoscopic approach is an alternative to open surgery. CONCLUSIONS: Gastrogastric fistula is a possible complication of Roux-en-Y gastric bypass and its laparoscopic treatment is feasible. 相似文献
86.
87.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
88.
Jan de Lange Thomas Putters Erik M Baas Johan M van Ingen 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2007,104(6):841-845
OBJECTIVE: The purpose of this study was to evaluate the potential benefit of an ultrasonic device in apical surgery on the outcome of treatment. STUDY DESIGN: A randomized prospective design was used in a standardized treatment protocol. Patients were allocated to treatment with an ultrasonic device (P-Max Newtron) or treatment with a bur in an otherwise similar protocol. One year after treatment the results were evaluated by 2 oral and maxillofacial surgeons who were blinded for the therapy. RESULTS: Out of a total group of 399 patients who were included in the study, adequate follow-up could be obtained in 290 patients. The overall success rate in the ultrasonic group was 80.5% and in the group treated with a bur 70.9% (P = .056). In molars, the difference in success rate was significant (P = .02). CONCLUSION: The use of an ultrasonic device in apical surgery improved the outcome of treatment. In molars this effect was significant. 相似文献
89.
G. Y. Meyer‐Rochow A. J. Gill L. W. Delbridge S. B. Sidhu M. S. Sywak 《ANZ journal of surgery》2007,77(Z1):A22-A22
Purpose Parathyroid carcinoma (PC) is rare and accounts for less than 1% of all cases of primary hyperparathyroidism (PHPT). The definitive histopathologic diagnosis of PC requires unequivocal invasion or metastasis which may be absent at first presentation. As a result, many cases of PC can only be diagnosed retrospectively. Parafibromin is the protein encoded by HRPT2 which is mutated and not expressed in many parathyroid carcinomas. Given that PCs generally weigh more than parathyroid adenomas (PA)s, we hypothesized that amongst large PAs there may be a high incidence of occult PC which could be identified by negative staining for parafibromin. Methodology 57 parathyroid glands weighing greater than 2 grams excised from 1998–2006 were identified from the University of Sydney Endocrine Surgical Database. Two specimens with a histopathologic diagnosis of PC were excluded. Immunohistochemical staining for parafibromin was performed on the remaining 55 PAs. Results Of the 55 specimens stained for parafibromin only one definite negative stain was detected. This case was originally classified as an “atypical adenoma” because it showed nuclear and architectural atypia without unequivocal evidence of invasive growth. In view of the negative staining for parafibromin it therefore probably represents occult carcinoma. There has been no evidence of recurrence or metastasis after 6.5 years. Conclusions Complete loss of staining for parafibromin is very rare in giant parathyroid adenomas suggesting that occult carcinoma is equally rare. As a result routine immunohistochemical staining for parafibromin does not appear to be an effective screening test for carcinoma in large PA without histopathologic features of PC. 相似文献
90.